Minako Ono

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A production system for a therapeutic monoclonal antibody was developed using the methylotrophic yeast Ogataea minuta IFO10746. The genetically engineered O. minuta secreted a detectable amount of anti-TRAIL receptor antibody into the culture supernatant, and the secreted antibody was purified by multiple column chromatography steps. In the purification(More)
  • 1